Literature DB >> 21812327

Tanshinone IIA prevents cardiac remodeling through attenuating NAD (P)H oxidase-derived reactive oxygen species production in hypertensive rats.

Ping Wang1, Xiaoqian Wu, Yingxia Bao, Jian Fang, Sigui Zhou, Jie Gao, Rongbiao Pi, Yong-Gao Mou, Peiqing Liu.   

Abstract

Tanshinone IIA is one of major constituents of Salvia miltiorrhiza Bunge known as Danshen. Our and others' studies have shown that Tan IIA could protect cardimyocyte against apoptosis; however the effect of Tan IIA on cardiac remodeling disease is still unknown. In this study, we investigated the effects of Tan IIA on cardiac hypertrophy and fibrosis in two-kidney, two-clip (2K2C) hypertensive rats and by which, if any, mechanisms. Administration of 2K2C hypertensive rats with Tan IIA attenuated cardiac dysfunction and fibrosis. However Tan IIA treatment had no effects on BP control. Further studies revealed that Tan IIA inhibited the increased NAD(P)H oxidase activity and expression as well as O2*- production in 2K2C hypertensive rats. Our results indicated that Tan IIA significantly improved cardiac function and attenuated fibrosis in 2K2C hypertensive rats. The protective action of Tan IIA is likely mediated by its antioxidant effect, independent of BP control, partially via inhibiting NADPH oxidase.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812327

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  16 in total

1.  Tanshinone IIA protects against methylglyoxal-induced injury in human brain microvascular endothelial cells.

Authors:  Wen-Jing Zhou; Qi-Feng Gui; Yue Wu; Yun-Mei Yang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Sodium tanshinone IIA sulfonate inhibits canonical transient receptor potential expression in pulmonary arterial smooth muscle from pulmonary hypertensive rats.

Authors:  Jian Wang; Qian Jiang; Limei Wan; Kai Yang; Yi Zhang; Yuqin Chen; Elizabeth Wang; Ning Lai; Lei Zhao; Hua Jiang; Yueqian Sun; Nanshan Zhong; Pixin Ran; Wenju Lu
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-11       Impact factor: 6.914

Review 3.  Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Authors:  Zhuo-Ming Li; Suo-Wen Xu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

4.  Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.

Authors:  Yan-rong Jiang; Zhen-hai Zhang; Qi-yuan Liu; Shao-ying Hu; Xiao-yun Chen; Xiao-bin Jia
Journal:  Int J Nanomedicine       Date:  2013-06-25

Review 5.  Current status of NADPH oxidase research in cardiovascular pharmacology.

Authors:  Bruno K Rodiño-Janeiro; Beatriz Paradela-Dobarro; María Isabel Castiñeiras-Landeira; Sergio Raposeiras-Roubín; José R González-Juanatey; Ezequiel Alvarez
Journal:  Vasc Health Risk Manag       Date:  2013-07-25

Review 6.  Oxidative Stress and Salvia miltiorrhiza in Aging-Associated Cardiovascular Diseases.

Authors:  Cheng-Chieh Chang; Yu-Chun Chang; Wen-Long Hu; Yu-Chiang Hung
Journal:  Oxid Med Cell Longev       Date:  2016-10-11       Impact factor: 6.543

7.  Characterization and Stability of Tanshinone IIA Solid Dispersions with Hydroxyapatite.

Authors:  Xiaopan Wang; Li Li; Wei Huo; Lulu Hou; Zhiying Zhao; Weiguang Li
Journal:  Materials (Basel)       Date:  2013-03-06       Impact factor: 3.623

8.  The complex regulation of tanshinone IIA in rats with hypertension-induced left ventricular hypertrophy.

Authors:  Hui Pang; Bing Han; Tao Yu; Zhen Peng
Journal:  PLoS One       Date:  2014-03-19       Impact factor: 3.240

9.  Enhanced dissolution and stability of Tanshinone IIA base by solid dispersion system with nano-hydroxyapatite.

Authors:  Yan-Rong Jiang; Zhen-Hai Zhang; Sai-Yan Huang; Yan Lu; Tian-Tian Ma; Xiao-Bin Jia
Journal:  Pharmacogn Mag       Date:  2014-07       Impact factor: 1.085

10.  An attempt to stabilize tanshinone IIA solid dispersion by the use of ternary systems with nano-CaCO3 and poloxamer 188.

Authors:  Hong-Mei Yan; Zhen-Hai Zhang; Yan-Rong Jiang; Dong-Mei Ding; E Sun; Xiao-Bin Jia
Journal:  Pharmacogn Mag       Date:  2014-04       Impact factor: 1.085

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.